These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3607369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C, Meyer W, Scholz H, Starbatty J.
    Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B, Sebening H, Hartmann F, Klein G.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC, Diederen W.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ, van der Giessen WJ, Verdouw PD.
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G, Ningel K, Permanetter B.
    J Cardiovasc Pharmacol; 1989 Sep; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [Abstract] [Full Text] [Related]

  • 9. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
    Endoh M, Shibasaki T, Satoh H, Norota I, Ishihata A.
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R, van der Weerd RW, Haitsma DB, Verdouw PD, Duncker DJ.
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
    Westfall MV, Wahler GM, Fujino K, Solaro RJ.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):58-63. PubMed ID: 1346167
    [Abstract] [Full Text] [Related]

  • 14. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM, Lynch JJ, Driscoll EM, Lucchesi BR.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium.
    Takahashi R, Endoh M.
    J Cardiovasc Pharmacol; 2001 Feb; 37(2):209-18. PubMed ID: 11210003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.